The upper and lower respiratory tract microbiome in severe aspiration pneumonia
Georgios D. Kitsios, Vi D. Nguyen, Khaled Sayed, Nameer Al‐Yousif, Caitlin Schaefer, Faraaz Shah, William Bain, Haopu Yang, Adam Fitch, Kelvin Li, Xiaohong Wang, Shulin Qin, Heather Gentry, Yingze Zhang, Jack Varon, Antonio Arciniegas Rubio, Joshua A. Englert, Rebecca M. Baron, Janet Lee, Barbara A. Methé, Panayiotis V. Benos, Alison Morris, Bryan J. McVerry
Abstract
Uncertainty persists whether anaerobic bacteria represent important pathogens in aspiration pneumonia. In a nested case-control study of mechanically ventilated patients classified as macro-aspiration pneumonia (MAsP, n = 56), non-macro-aspiration pneumonia (NonMAsP, n = 91), and uninfected controls (n = 11), we profiled upper (URT) and lower respiratory tract (LRT) microbiota with bacterial 16S rRNA gene sequencing, measured plasma host-response biomarkers, analyzed bacterial communities by diversity and oxygen requirements, and performed unsupervised clustering with Dirichlet Multinomial Models (DMM). MAsP and NonMAsP patients had indistinguishable microbiota profiles by alpha diversity and oxygen requirements with similar host-response profiles and 60-day survival. Unsupervised DMM clusters revealed distinct bacterial clusters in the URT and LRT, with low-diversity clusters enriched for facultative anaerobes and typical pathogens, associated with higher plasma levels of SPD and sCD14 and worse 60-day survival. The predictive inter-patient variability in these bacterial profiles highlights the importance of microbiome study in patient sub-phenotyping and precision medicine approaches for severe pneumonia.